Effects of promyelocytic leukemia protein on virus-host balance.
The cellular promyelocytic leukemia protein (PML) associates with the proteins of several viruses and in some cases reduces viral propagation in cell culture. To examine the role of PML in vivo, we compared immune responses and virus loads of PML-deficient and control mice infected with lymphocytic...
Main Authors: | , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2002
|
_version_ | 1797053296305766400 |
---|---|
author | Bonilla, W Pinschewer, D Klenerman, P Rousson, V Gaboli, M Pandolfi, P Zinkernagel, R Salvato, MS Hengartner, H |
author_facet | Bonilla, W Pinschewer, D Klenerman, P Rousson, V Gaboli, M Pandolfi, P Zinkernagel, R Salvato, MS Hengartner, H |
author_sort | Bonilla, W |
collection | OXFORD |
description | The cellular promyelocytic leukemia protein (PML) associates with the proteins of several viruses and in some cases reduces viral propagation in cell culture. To examine the role of PML in vivo, we compared immune responses and virus loads of PML-deficient and control mice infected with lymphocytic choriomeningitis virus (LCMV) and vesicular stomatitis virus (VSV). PML(-/-) mice exhibited accelerated primary footpad swelling reactions to very-low-dose LCMV, higher swelling peaks upon high-dose inoculation, and higher viral loads in the early phase of systemic LCMV infection. T-cell-mediated hepatitis and consequent mortality upon infection with a hepatotropic LCMV strain required 10- to 100-times-lower inocula despite normal cytotoxic T-lymphocyte reactivity in PML(-/-) mice. Furthermore, PML deficiency rendered mice 10 times more susceptible to lethal immunopathology upon intracerebral LCMV inoculation. Accordingly, 10-times-lower VSV inocula elicited specific neutralizing-antibody responses, a replication-based effect not observed with inactivated virus or after immunization with recombinant VSV glycoprotein. These in vivo observations corroborated our results showing more virus production in PML(-/-) fibroblasts. Thus, PML is a contributor to innate immunity, defining host susceptibility to viral infections and to immunopathology. |
first_indexed | 2024-03-06T18:41:50Z |
format | Journal article |
id | oxford-uuid:0d1b9635-5783-4a93-8eb1-65997756ec10 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T18:41:50Z |
publishDate | 2002 |
record_format | dspace |
spelling | oxford-uuid:0d1b9635-5783-4a93-8eb1-65997756ec102022-03-26T09:38:50ZEffects of promyelocytic leukemia protein on virus-host balance.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0d1b9635-5783-4a93-8eb1-65997756ec10EnglishSymplectic Elements at Oxford2002Bonilla, WPinschewer, DKlenerman, PRousson, VGaboli, MPandolfi, PZinkernagel, RSalvato, MSHengartner, HThe cellular promyelocytic leukemia protein (PML) associates with the proteins of several viruses and in some cases reduces viral propagation in cell culture. To examine the role of PML in vivo, we compared immune responses and virus loads of PML-deficient and control mice infected with lymphocytic choriomeningitis virus (LCMV) and vesicular stomatitis virus (VSV). PML(-/-) mice exhibited accelerated primary footpad swelling reactions to very-low-dose LCMV, higher swelling peaks upon high-dose inoculation, and higher viral loads in the early phase of systemic LCMV infection. T-cell-mediated hepatitis and consequent mortality upon infection with a hepatotropic LCMV strain required 10- to 100-times-lower inocula despite normal cytotoxic T-lymphocyte reactivity in PML(-/-) mice. Furthermore, PML deficiency rendered mice 10 times more susceptible to lethal immunopathology upon intracerebral LCMV inoculation. Accordingly, 10-times-lower VSV inocula elicited specific neutralizing-antibody responses, a replication-based effect not observed with inactivated virus or after immunization with recombinant VSV glycoprotein. These in vivo observations corroborated our results showing more virus production in PML(-/-) fibroblasts. Thus, PML is a contributor to innate immunity, defining host susceptibility to viral infections and to immunopathology. |
spellingShingle | Bonilla, W Pinschewer, D Klenerman, P Rousson, V Gaboli, M Pandolfi, P Zinkernagel, R Salvato, MS Hengartner, H Effects of promyelocytic leukemia protein on virus-host balance. |
title | Effects of promyelocytic leukemia protein on virus-host balance. |
title_full | Effects of promyelocytic leukemia protein on virus-host balance. |
title_fullStr | Effects of promyelocytic leukemia protein on virus-host balance. |
title_full_unstemmed | Effects of promyelocytic leukemia protein on virus-host balance. |
title_short | Effects of promyelocytic leukemia protein on virus-host balance. |
title_sort | effects of promyelocytic leukemia protein on virus host balance |
work_keys_str_mv | AT bonillaw effectsofpromyelocyticleukemiaproteinonvirushostbalance AT pinschewerd effectsofpromyelocyticleukemiaproteinonvirushostbalance AT klenermanp effectsofpromyelocyticleukemiaproteinonvirushostbalance AT roussonv effectsofpromyelocyticleukemiaproteinonvirushostbalance AT gabolim effectsofpromyelocyticleukemiaproteinonvirushostbalance AT pandolfip effectsofpromyelocyticleukemiaproteinonvirushostbalance AT zinkernagelr effectsofpromyelocyticleukemiaproteinonvirushostbalance AT salvatoms effectsofpromyelocyticleukemiaproteinonvirushostbalance AT hengartnerh effectsofpromyelocyticleukemiaproteinonvirushostbalance |